COVID-19-induced vascular angiopathy: CTPA signs in critically ill patients other than acute pulmonary embolism and high-lung opacity scores
Open Access
- 19 April 2021
- journal article
- research article
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 52 (1) , 1-10
Abstract
Background: Vascular angiopathy is suggested to be the major cause of silent hypoxia among COVID-19 patients without severe parenchymal involvement. However, pulmonologists and clinicians in intensive care units become confused when they encounter acute respiratory deterioration with neither severe parenchymal lung involvement nor acute pulmonary embolism. Other radiological vascular signs might solve this confusion. This study investigated otherindirect vascular angiopathy signson CT pulmonary angiography (CTPA) and involved a novel statistical analysis that was performed to determine the significance of associations between these signs and the CT opacity score of the pathological lung volume, which is calculated by an artificial intelligence system.Results: The study was conducted retrospectively, during September and October 2020, on73 patients with critical COVID-19who were admitted to the ICU with progressive dyspnea and low O2saturation on room air (PaO2< 93%). They included 53 males and 20 females (73%:27%), and their age ranged from 18 to 88 years (mean ± SD=53.3 ± 13.5).CT-pulmonary angiographywas performed for all patients, and anartificial intelligence systemwas utilized to quantitatively assess the diseased lung volume. The radiological data were analyzed by three expert consultant radiologists to reach consensus. A low CT opacity score (≤10) was found in 18 patients (24.7%), while a high CT opacity score (>10) was found in 55 patients (75.3%). Pulmonary embolism was found in 24 patients (32.9%); three of them had low CT opacity scores. Four other indirect vasculopathy CTPA signs were identified: (1) pulmonary vascular enlargement (57 patients—78.1%), (2) pulmonary hypertension (14 patients—19.2%), (3) vascular tree-in-bud pattern (10 patients—13.7%), and (4) pulmonary infarction (three patients—4.1%). There were no significant associations between these signs and the CT opacity score (0.3205–0.7551, all >0.05). Furthermore, both pulmonary vascular enlargement and the vascular tree-in-bud sign were found in patients without pulmonary embolism and low CT-severity scores (13/15–86.7% and 2/15–13.3%, respectively).Conclusion: Pulmonary vascular enlargement or, less commonly, vascular tree-in-bud pattern are both indirect vascular angiopathy signs on CTPA that can explain the respiratory deterioration which complicates COVID-19 in the absence of severe parenchymal involvement or acute pulmonary embolism.Keywords
This publication has 15 references indexed in Scilit:
- Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to DateAmerican Journal of Roentgenology, 2020
- Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer LevelsRadiology, 2020
- Chest CT Features of COVID-19 in Rome, ItalyRadiology, 2020
- Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CTRadiology, 2020
- Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and ManagementAmerican Journal of Roentgenology, 2020
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19New England Journal of Medicine, 2020
- Pulmonary embolism in patients with COVID-19 pneumoniaEuropean Respiratory Journal, 2020
- COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Medicine, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- Anti-Chinese sentiment during the 2019-nCoV outbreakThe Lancet, 2020